• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.30%

    AbbVie Inc. (ABBV)

    -NYSE
    68.35 Up 0.14(0.21%) 12:02PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:68.21
    Open:67.53
    Bid:68.42 x 400
    Ask:68.43 x 400
    1y Target Est:74.00
    Beta:1.63
    Next Earnings Date:24-Jul-15ABBV Earnings announcement
    Day's Range:67.65 - 69.00
    52wk Range:51.37 - 70.76
    Volume:2,461,144
    Avg Vol (3m):10,841,600
    Market Cap:108.89B
    P/E (ttm):61.03
    EPS (ttm):1.12
    Div & Yield:2.04 (2.90%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Featured on Yahoo Finance

    Comparison

    Symbol% ChgMkt Cap
    ABBVUp 0.21%108.89B
    MRKDown 0.29%162.45B
    NVSDown 1.16%238.74B
    PFEDown 0.18%205.11B

    Key Statistics

    Forward P/E (1 yr):13.66
    P/S (ttm):5.32
    Ex-Dividend Date:13-Jul-15

    Analysts

    Annual EPS Est (Dec-15) :4.24
    Quarterly EPS Est (Jun-15) :1.05
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback